The performance of the CASPAR criteria, which are known to have high specificity and sensitivity in classifying patients with long-standing psoriatic arthritis, has now been evaluated in early disease. Whereas the findings are likely to boost clinical research, implications for daily practice—and diagnosis—are less certain.
